CONJUGUÉS ANTICORPS ANTI-CD22-MAYTANSINE, ASSOCIATIONS ET MÉTHODES D'UTILISATION CORRESPONDANTES

• 收藏
• 分享

专利权人:

Triphase Research And Development III Corp.

发明人:

申请号：

EP18888720.2

公开号：

EP3723763A2

申请日:

2018.12.11

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present disclosure provides methods for treating a cancer or resistant cancer with a combination of an anti-CD22 antibody-maytansine conjugate and one or more anti-cancer agents. The disclosure also encompasses methods for sensitizing a cancer with such combinations. Also provided are pharmaceutical compositions including such combinations.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/